Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Flunixin Meglumine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of flunixin meglumine intermediate via high-pressure fluorination. Delivers high purity and scalable manufacturing for veterinary pharmaceuticals.
Novel synthetic route for flunixin meglumine intermediate using p-toluenesulfonic acid. High yield, cost-effective, scalable process for veterinary pharmaceutical manufacturing.
Patent CN114890902B details a safer, two-step synthesis for 2-methyl-3-trifluoromethyl aniline, offering significant cost reduction in API manufacturing.